[Federal Register Volume 59, Number 183 (Thursday, September 22, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-23375]


[[Page Unknown]]

[Federal Register: September 22, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 

Request for Nominations for Members on Public Advisory 
Committees; Science Advisory Board to the National Center for 
Toxicological Research

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Science Advisory Board (the 
board) to the National Center for Toxicological Research. Three 
vacancies will occur on June 30, 1995.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, extends particular encouragement to 
nominations for appropriately qualified female, minority, and 
physically disabled candidates. Final selections from among qualified 
candidates for each vacancy will be determined by the expertise 
required to meet specific agency needs and in a manner to ensure 
appropriate balance of membership.

DATES: Nominations should be received by October 24, 1994.

ADDRESSES: All nominations for membership, except for general public 
representatives (consumer-nominated members), should be sent to Barbara 
J. Jewell (address below). All nominations for general public 
representatives (consumer-nominated members) should be sent to Susan K. 
Meadows (address below).

FOR FURTHER INFORMATION CONTACT:
    Regarding all nominations for membership, except for general public 
representatives (consumer-nominated members): Barbara J. Jewell, 
National Center for Toxicological Research (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-3155.
    Regarding all nominations for general public representatives 
(consumer-nominated members): Susan K. Meadows, Office of Consumer 
Affairs (HFE-40), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-443-5006.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for members to 
serve on the board to the National Center for Toxicological Research 
(NCTR). The function of the board is to advise the Director, NCTR, on 
establishment and implementation of a research program that will assist 
in fulfilling the regulatory responsibilities of the Commissioner of 
Food and Drugs. The board provides an extra-agency review to ensure 
that the research programs at NCTR are scientifically sound and 
pertinent.

Criteria for Members

    Persons nominated for membership shall have adequately diversified 
experience that is appropriate to the work of the board in the fields 
related to toxicological research.
    The specialized training and experience necessary to qualify 
nominees as experts suitable forappointment are subject to review, but 
may include experiencein medical practice, teaching, and/or research 
relevant to the field of activity of the board. The term of office is 
up to 4 years, depending on the appointment date.

General Public Representatives (Consumer-nominated Members)

    FDA currently attempts to place on committees members who are 
nominated by consumer organizations. These members are recommended by a 
consortium of 12 consumer organizations that has the responsibility for 
screening, interviewing, and recommending consumer-nominated candidates 
with appropriate scientific credentials. Candidates are sought who are 
aware of the consumer impact of committee issues, but who also possess 
enough technical background to understand and contribute to the 
committee's work. For some advisory committees the agency notes, 
however, it may require such nominees to meet the same technical 
qualifications and specialized training required of other expert 
members of the committee. The term of office for these members is up to 
4 years, depending on the appointment date. Nominations are invited for 
consideration for membership as openings become available.

Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on the board. Nominations shall state that the nominee 
is aware of the nomination, is willing to serve as a member of the 
board, and appears to have no conflict of interest that would preclude 
board membership. Potential candidates will be asked by FDA to provide 
detailed information concerning such matters as financial holdings, 
consultancies, and research grants or contracts in order to permit 
evaluation of possible sources of conflict of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 15, 1994.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 94-23375 Filed 9-22-94; 8:45 am]
BILLING CODE 4160-01-F